United States House Ways and Means Subcommittee on Health

NAPEO SOUNDS ALARM AS IRS ERTC BACKLOG NOW TOPS ONE MILLION

Retrieved on: 
Tuesday, May 2, 2023
National Association of Black Accountants, Werfel, Small business, PEO, IRS, Senate, Capitol Hill, United States House Committee on Ways and Means, Professional employer organization, Congress, United States House Ways and Means Subcommittee on Health, United States Senate Committee on Finance, National Association, Ways and means committee, House, Cryptocurrency

ALEXANDRIA, Va., May 2, 2023 /PRNewswire/ -- The ballooning backlog of Employee Retention Credit (ERTC) applications reached a grim milestone last week, despite recent commitments from IRS Commissioner Daniel Werfel to double efforts to get small and mid-sized businesses this vital money.

Key Points: 
  • According to the IRS, the backlog of outstanding Forms 941-X —the application used by small businesses to claim the ERTC— now tops one million, a 641% increase since August.
  • "This staggering figure indicates the true severity of this crisis," said National Association of Professional Employer Organizations (NAPEO) President and CEO Pat Cleary.
  • A sampling of only 15% of NAPEO members found that 13,631 small business PEO clients are waiting for the IRS to approve roughly $3 billion worth of ERTC credits.
  • NAPEO, PEOs, and small business PEO clients remain in active communication with lawmakers and regulators to clear this backlog.

Sun Life and DentaQuest donate $100,000 to RIZE Massachusetts

Retrieved on: 
Wednesday, March 8, 2023
American Diabetes Association, National Alliance, Sun Life Financial, United States House Ways and Means Subcommittee on Health, Massachusetts Department of Public Health, Friends, Health, RIZE, Tooth fairy, Research, Kansas City metropolitan area, Dental care, Opioid, Black Alliance for Educational Options, National Alliance on Mental Illness, Face, Breakfast, Quality of life, Employment, Dentistry, Bay, Mental disorder, Death, Mental health, Diabetes, Courage, Public health, Mental, Organization, Greater Boston, Health equity, Family, YMCA, Hospital, Pharmaceutical industry, Nursing

WELLESLEY, Mass., March 8, 2023 /PRNewswire/ -- Sun Life U.S. and DentaQuest, part of Sun Life U.S., have donated $100,000 to RIZE Massachusetts, an independent nonprofit foundation solely dedicated to funding and creating solutions to end the opioid crisis.

Key Points: 
  • WELLESLEY, Mass., March 8, 2023 /PRNewswire/ -- Sun Life U.S. and DentaQuest, part of Sun Life U.S., have donated $100,000 to RIZE Massachusetts , an independent nonprofit foundation solely dedicated to funding and creating solutions to end the opioid crisis.
  • DentaQuest President and RIZE Board Chair Steve Pollock served as co-host of the event.
  • "DentaQuest and Sun Life support RIZE because we share a commitment to advancing health equity, which starts by expanding access to care and benefits, particularly for underserved populations.
  • "RIZE is grateful to receive this incredible gift from Sun Life and DentaQuest, which will help further our mission to end the overdose crisis in Massachusetts and improve quality of life for people with substance use disorders," said Julie Burns, president and CEO of RIZE Massachusetts Foundation.

PhRMA Foundation Announces New Members of Board of Directors

Retrieved on: 
Tuesday, November 29, 2022
UnitedHealth Group, Doctor of Philosophy, Pharmaceutical Research and Manufacturers of America, Medical school, Environment, Merck & Co., United States House Ways and Means Subcommittee on Health, Multimedia, Novartis, Bristol Myers Squibb, Physician, Policy, Patient, California Institute for Quantitative Biosciences, Research, Ways and means committee, Senior, Cancer, School, Translational medicine, Biogen, Commerce, Drug discovery, Stanford University School of Medicine, House Committee, Stanford University, Pharmaceutical industry, Management, Sanofi, Merck, MD, Cephalon, Medicine, Pfizer

The PhRMA Foundation is a 57-year-old nonprofit that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research.

Key Points: 
  • The PhRMA Foundation is a 57-year-old nonprofit that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research.
  • "These new Board members bring to the PhRMA Foundation a diversity of experience and perspective that is critical as we enter the next era of change for the biopharmaceutical industry," said Amy M. Miller, PhD, President of the PhRMA Foundation.
  • "I look forward to working with our Board of Directors to chart a path forward for the organization and support the rapidly evolving field."
  • "I look forward to working with my fellow Board members at the PhRMA Foundation to foster innovative research and inspire a new and diverse generation of biopharmaceutical scientists."

Capitol Counsel Adds Former Executive Director of Team McCarthy and Trailblazers Fund at CLF as Partner

Retrieved on: 
Thursday, November 17, 2022
American Action Network, CLF, Tax, House, Government, Republican, House Republican Conference, Senate Republican Conference, Senate, California State Senate, Congress, Ways and means committee, McCarthy, Politics, Policy, Congressional Leadership Fund, Electoral History of the Conservative Party of New York State (U.S. House Results), United States House Ways and Means Subcommittee on Health, Management, Public relations, Kip Bouknight

WASHINGTON, Nov. 17, 2022 /PRNewswire/ -- Capitol Counsel is adding another partner, further deepening their expertise in Republican politics and expanding their ties and government relations abilities in the U.S. House.

Key Points: 
  • Capitol Counsel Partner Denise Morrisey announced today that McCarthy and Congressional Leadership Fund (CLF) Alum, Nick Bouknight, will rejoin the firm as partner.
  • Nick previously worked at Capitol Counsel in 2018 as a principal.
  • He brings that insight and relationships to the team and will offer our clients valuable counsel as we navigate divided government," Morrisey said.
  • In the 2020 and 2018 election cycles, Nick was Executive Director of Republican Leader Kevin McCarthy's political operation.

Announcing the Launch of the First Nation-Wide Bedsore Litigation Firm

Retrieved on: 
Tuesday, February 22, 2022
GLOBE, Mouth ulcer, News, Death, Elder abuse, IV, Nursing Home Reform Act, Consumer Attorneys Association of Los Angeles, Pressure ulcer, 1,000,000, Nursing, United States House Ways and Means Subcommittee on Health, Skin, Pressure, Association, Infection, Pharmaceutical industry, Medicine

Bedsore.Law is the first nation-wide bedsore specialty litigation firm in the U.S.

Key Points: 
  • Bedsore.Law is the first nation-wide bedsore specialty litigation firm in the U.S.
  • Bedsore litigation can be complex and requires experienced attorneys to handle each case.
  • "Bedsores are preventable with proper custodial care and monitoring," said founding partner and bedsore lawyer Jeff Aidikoff.
  • They have bedsore attorney offices throughout California, Texas, Wyoming, and Oklahoma, with partner firms in all 50 states.

Rare Disease Diversity Coalition Urges Congress to Preserve Incentives for Development of Treatments

Retrieved on: 
Monday, November 1, 2021
People, Linda, Woman, Sickle cell disease, Research, Orphan Drug Act of 1983, Orphan drug, Black Women's Health Imperative, Disease, Goal, Failure, Ways and means committee, Social justice, Health equity, Patient, United States House Ways and Means Subcommittee on Health, Policy, Education, Mastocytosis, Government, Congress, Black women, Color, Building Back Better, Plague, Bias, CEO, Degenerative disease, MPH, Letter, Multimedia, SEC, Credit, Rare disease, Health, Black, Hodgkin lymphoma, Act, Pharmaceutical industry

The House Ways and Means Committee included a provision in its version of the reconciliation bill -- Sec. 138141, the "Credit for Clinical Testing of Orphan Drugs Limited to First Use or Indication" -- that would limit the number of rare disease drugs that can qualify for government assistance under the Orphan Drug Act.

Key Points: 
  • WASHINGTON, Nov. 1, 2021 /PRNewswire/ --The Rare Disease Diversity Coalition recently sent a letter urging lawmakers not to change the Orphan Drug Act as part of the budget reconciliation package making its way through Congress.
  • In 1983, Congress passed the Orphan Drug Act to incentivize the development of treatments for rare diseases -- those that affect fewer than 200,000 people.
  • Through tax credits and other incentives, the Act helps offset the cost of developing and testing therapies for these conditions.
  • The Black Women's Health Imperative launched the Rare Disease Diversity Coalition to address the extraordinary challenges faced by rare disease patients of color.